Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Sangamo Biosciences, Inc. (NQ: SGMO)
7.980 USD  +0.050 (+0.63%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 7.960
Bid (Size) 7.980 (2200)
Ask (Size) 7.990 (15600)
Prev. Close 7.930
Today's Range 7.770 - 8.180
52wk Range 4.040 - 11.24
Shares Outstanding 53,747,385
Dividend Yield N/A
Top News
More News
Sangamo Biosciences (SGMO) gets $6.4 M from CIRM – BUY
Today 9:04 EDT
    Strategic Partnership Award from California Institute for Regenerative Medicine   SGMO receives $6.4 Million Strategic Partnership Award From California Institute for Regenerative Medicine (CIRM)... Read More
category Henry McCusker
from Bio-Wire.Com
Sangamo BioSciences Receives $6.4M Strategic Partnership Award from CIRM
Today 7:02 EDT
Sangamo BioSciences, Inc. (NASDAQ: SGMO ) announced that the California Institute for Regenerative Medicine (CIRM) has granted the Company a $6.4 million Strategic Partnership Award to develop a... Read More
category Contracts , Management , Benzinga , and 4 more.
from Latest Articles from Benzinga.com

More News
Read More
Sangamo BioSciences Receives $6.4 Million Strategic Partnership Award From California Institute for Regenerative Medicine (CIRM) to Develop ZFP Therapeutic® for Beta-thalassemia
Today 7:00 EDT
from PR Newswire
Investors Lock In Profits
May 20, 2013
category Market News
from MarketMinute.com Market Updates
Bio-Wire Equity Surveillance – Closing Bell 5/20/2013
May 20, 2013
category RPTP , ACAD , MDXG , and 15 more.
from Bio-Wire.Com
Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago Sangamo Biosciences Is Up 7.1% (SGMO)
May 20, 2013
from Comtex SmarTrend® News Briefs
Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases
May 20, 2013
from PR Newswire
Shares of Sangamo Biosciences Are Down on Strong Volume (SGMO)
May 15, 2013
from Comtex SmarTrend® News Briefs
UPDATE: Sangamo Highlights Encouraging Preliminary Anti-Viral HIV Data during Treatment Interruption in Ongoing SB-728-T Phase 2 Trials
May 15, 2013
category Benzinga , News , FDA , and 1 more.
from Latest Articles from Benzinga.com
Sangamo BioSciences Presents Clinical Data Demonstrating HIV Reservoir Reduction in HIV-Infected Subjects Treated with ZFP Therapeutic®, SB-728-T
May 15, 2013
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here